Médecins pour Cancer de la prostate à l'étranger — Page 4

Professor Liang Xiaoxiao is the Department Director and Chief Physician in Neurorehabilitation. She holds a master’s degree in neurology. She is skilled in neuromodulation for disorders of consciousness, cognition, and movement. Her focus includes cases from cerebrovascular disease, Parkinson’s disease, and related conditions. She also performs ultrasound-guided botulinum toxin injections for blepharospasm, hemifacial spasm, limb spasticity, sialorrhea, and neuralgia.

Accreditations and roles: Member of the Neurorehabilitation, Cognitive Disorder Rehabilitation, and Craniocerebral Trauma Rehabilitation Committees of the Chinese Association of Rehabilitation Medicine. Standing Member of the Cognitive Disorder Rehabilitation Committee of the Fujian Association of Rehabilitation Medicine. Vice Chair of the Dementia and Cognitive Disorder Committee of the Xiamen Preventive Medicine Association. Vice President of the Parkinson’s Disease and Movement Disorders Committee of the Xiamen Medical Doctor Association. Standing Member of the Neuromodulation Committee of the Xiamen Medical Doctor Association. Recipient of the Most Beautiful Physician of Xiamen City (2024).

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Le Dr Ozden apporte plus de 20 ans d'expérience médicale, se spécialisant dans le traitement du cancer de la prostate à l'hôpital VM Medical Park Pendik.

• Diplômé de la prestigieuse faculté de médecine Cerrahpaşa de l'université d'Istanbul
• Spécialisation en oncologie médicale complétée à l'université de Kocaeli
• Vaste expérience en médecine interne avant de se concentrer sur l'oncologie

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Le Pr. agrégé Nail Paksoy est spécialisé dans le traitement du cancer de la prostate à l'hôpital Medipol Bahçelievler, avec une certification de l'ESMO en oncologie médicale.

• Achever une bourse de recherche en oncologie médicale à l'Institut d'oncologie de l'Université d'Istanbul
• Publier des recherches sur la charge tumorale au PSMA dans le cancer de la prostate
• Participer à des essais cliniques internationaux pour des traitements avancés contre le cancer
• Être certifié par l'ESMO en oncologie médicale depuis 2022

Dr. Ayşe İrem Yasin is a medical oncologist at Medipol Acıbadem District Hospital in Istanbul. She holds a prestigious ESMO Board Certificate. Dr. Yasin specializes in solid tumors, including breast, lung, and gastrointestinal cancers. She treats complex cases such as Merkel cell carcinoma and cancers of unknown primary.

• Trained at Harvard Medical School, Cleveland Clinic, and Basel University Hospital.
• Completed a clinical observership at the Breast Cancer Unit in Novara, Italy.
• Treats brain and CNS malignancies, soft tissue sarcomas, and urologic cancers.
• Works at a JCI-accredited facility equipped with the da Vinci robotic system.

Dr. Atakan Topcu is a medical oncologist at Medipol Acibadem District Hospital in Istanbul. He specializes in treating solid tumors including lung, breast, and colorectal cancers. Dr. Topcu is an Associate Professor with over 50 peer-reviewed scientific publications. He sits on the Editorial Board of the medical journal BMC Cancer.

• Expertise in immunotherapy, targeted therapies, and geriatric oncology care.
• Treats cancer-related malnutrition, cachexia, and sarcopenia.
• Maintains active membership in the European Society for Medical Oncology (ESMO).
• Works at a JCI-accredited hospital specializing in advanced oncology treatments.

Le Dr Alemdar apporte plus de 15 ans d'expérience médicale, se spécialisant dans le traitement du cancer de la prostate au complexe hospitalier Medical Park Antalya.

• Certifié en oncologie médicale avec une formation spécialisée à l'université d'Akdeniz
• Vaste expérience dans les hôpitaux universitaires et publics en Turquie
• Expert dans les derniers protocoles de traitement du cancer de la prostate
• Se concentrer sur des plans de traitement personnalisés adaptés aux besoins de chaque patient

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Le professeur Gul Alco est spécialisé en radio-oncologie pour le cancer de la prostate à l'Université Medipol d'Istanbul.

• Plus de 20 ans d'expérience en radio-oncologie
• Professeur associé puis professeur à l'Université Demiroglu Bilim
• Résidence effectuée à l'Université Kadir Has
• Exerce à l'hôpital de district Medipol Acibadem

Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.

Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.

Dr. Mohamed Mahmoud Abdelhakim is a Professor of Radiation Oncology at Cairo University’s National Cancer Institute. He serves as the Head of Radiation Oncology at Shefa al Orman Hospital. Dr. Abdelhakim treats complex cancers, including breast, soft tissue sarcoma, and gynecologic tumors. He is a member of ESTRO and ESMO.

• Performs image-guided brachytherapy and stereotactic radiotherapy.
• Uses IMRT, VMAT, SRS, and SBRT for precise tumor targeting.
• Provides total body and total skin irradiation for bone marrow transplants.
• Practices at ESMO-accredited Shefa al Orman Hospital in Luxor.

Dirige le département de chirurgie oncologique au centre médical Rabin et mène des études cliniques avancées en oncourologie.

• 25 ans d'expérience en tant que spécialiste en oncologie et oncourologie
• Spécialisation dans les tumeurs urologiques telles que le cancer de la prostate, du rein et de la vessie
• Responsable de nombreux essais de recherche clinique expérimentale internationaux
• Conférencier actif et participant à des forums internationaux d'oncologie

Le Dr Joseba Rebollo Liceaga possède plus de 25 ans de leadership en oncologie, ayant notamment dirigé des services dans de grands hôpitaux en Espagne.

• Spécialiste en oncologie médicale de la Clínica Universidad de Navarra
• Diriger des services d'oncologie dans plusieurs hôpitaux espagnols de premier plan
• Publier des recherches sur des traitements innovants tels que l'électrochimiothérapie
• Se former à la prestigieuse Université de Navarre
• Pratique actuelle axée sur la prise en charge globale du cancer

Le professeur Serkan Deveci dirige le service d'urologie de Medical Park Göztepe, ayant publié plus de 30 articles de recherche sur les résultats du cancer de la prostate.

• Spécialisé dans la prostatectomie robot-assistée et les techniques de préservation nerveuse
• Membre de l'American Urology Association et de l'Association Turque d'Urologie
• Éditeur de section pour le contenu urologique d'UpToDate – une référence pour les médecins du monde entier
• 621 citations témoignent de l'impact de ses recherches sur le traitement du cancer de la prostate

Urologiste, chirurgien

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Le Prof. Arie Lindner dirige le département d'urologie du centre médical Assaf Harofeh, se spécialisant dans les chirurgies complexes de la prostate.

• Formé au programme d'urologie de l'UCLA à Los Angeles
• Expert en traitements laser pour les pathologies de la prostate
• Membre des associations américaine, européenne et israélienne d'urologie
• Président du syndicat des médecins d'Israël